Press Releases Celcuity Inc.

Equities

CELC

US15102K1007

Real-time Estimate Cboe BZX Other stock markets 01:57:22 2024-04-29 pm EDT			5-day change	1st Jan Change
16.25 ^USD	+2.07%		-7.30%	+11.60%

Mar. 29	Celcuity Inc. Enters into Second Amendment to its Existing Loan and Security Agreement	CI
Mar. 28	Craig Hallum Adjusts Celcuity Price Target to $25 From $20, Maintains Buy Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences	Apr. 04	AQ
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 27	AQ
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call	Mar. 20	AQ
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024	Mar. 06	AQ
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference	Feb. 28	AQ
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer	Feb. 22	AQ
Celcuity Appoints Eldon Mayer as Chief Commercial Officer	Feb. 20	AQ
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium	Dec. 06	AQ
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium	Dec. 01	AQ
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference	Nov. 22	AQ
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates	Nov. 13	AQ
Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call	Nov. 06	AQ
Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences	Nov. 01	AQ
Celcuity Inc. Announces $50 Million Private Placement	23-10-19	AQ
Celcuity : Science Day Presentation	23-09-21	PU
Celcuity to Host Virtual Science Day for Investors	23-09-07	AQ
Celcuity Enters into a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa® (darolutamide) for Planned Phase 1b/2 Clinical Trial	23-08-22	AQ
Celcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial in Metastatic Castration Resistant Prostate Cancer	23-08-22	AQ
Celcuity Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Updates	23-08-10	AQ
Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call	23-08-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Celcuity Inc.

Equities

CELC

US15102K1007

Press Releases

Filters